Global Pancreatin Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-03-14
- Report ID: 66029
- Pages: 101
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Pancreatin market in this environment.
In terms of revenue, this research report indicated that the global Pancreatin market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Pancreatin industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Nordmark aims at producing XX K Units Pancreatin in 2020, with XX % production to take place in global market, Sichuan Deebio accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Pancreatin Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Pancreatin Market
Nordmark
Sichuan Deebio
Shenzhen Hepalink
Chongqing Aoli
ALI
Sichuan Biosyn
BIOZYM
Biocatalysts
Bovogen Biologicals
Spectrum Chemicals
...
Major Type of Pancreatin Covered in Prudent Markets report:
Pancreatin Powder
Pancreatin Pellets
Application Segments Covered in Prudent Markets Market
Food Processing
Pharma Industry
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Pancreatin Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Pancreatin Powder -Product Introduction and Major Manufacturers
1.1.2 Pancreatin Pellets -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Pancreatin Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Pancreatin Market
3.1.1 Top Companies leading Pancreatin Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Pancreatin Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Pancreatin Market
3.2.1 Top Companies leading Pancreatin Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Pancreatin Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Pancreatin Market
3.3.1 Top Companies leading Pancreatin Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Pancreatin Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Pancreatin Market
3.4.1 Top Companies leading Pancreatin Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Pancreatin Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Pancreatin Market
3.5.1 Top Companies leading Pancreatin Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Pancreatin Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Pancreatin Market
3.6.1 Top Companies leading Pancreatin Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Pancreatin Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Pancreatin Market
3.7.1 Top Companies leading Pancreatin Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Pancreatin Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Pancreatin Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Pancreatin Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Pancreatin Sales and Growth Rate (2021-2027)
5.2 Global Pancreatin Sales Value and Growth Rate (2021-2027)
6 Pancreatin Competitive Analysis
6.1 Nordmark
6.1.1 Nordmark Company Profiles
6.1.2 Nordmark Product Introduction
6.1.3 Nordmark Pancreatin Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Sichuan Deebio
6.2.1 Sichuan Deebio Company Profiles
6.2.2 Sichuan Deebio Product Introduction
6.2.3 Sichuan Deebio Pancreatin Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Shenzhen Hepalink
6.3.1 Shenzhen Hepalink Company Profiles
6.3.2 Shenzhen Hepalink Product Introduction
6.3.3 Shenzhen Hepalink Pancreatin Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Chongqing Aoli
6.4.1 Chongqing Aoli Company Profiles
6.4.2 Chongqing Aoli Product Introduction
6.4.3 Chongqing Aoli Pancreatin Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 ALI
6.5.1 ALI Company Profiles
6.5.2 ALI Product Introduction
6.5.3 ALI Pancreatin Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Sichuan Biosyn
6.6.1 Sichuan Biosyn Company Profiles
6.6.2 Sichuan Biosyn Product Introduction
6.6.3 Sichuan Biosyn Pancreatin Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 BIOZYM
6.7.1 BIOZYM Company Profiles
6.7.2 BIOZYM Product Introduction
6.7.3 BIOZYM Pancreatin Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Biocatalysts
6.8.1 Biocatalysts Company Profiles
6.8.2 Biocatalysts Product Introduction
6.8.3 Biocatalysts Pancreatin Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Bovogen Biologicals
6.9.1 Bovogen Biologicals Company Profiles
6.9.2 Bovogen Biologicals Product Introduction
6.9.3 Bovogen Biologicals Pancreatin Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Spectrum Chemicals
6.10.1 Spectrum Chemicals Company Profiles
6.10.2 Spectrum Chemicals Product Introduction
6.10.3 Spectrum Chemicals Pancreatin Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
